Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Bernardino Alcazar Navarrete (Cájar, Spain), Bernardino Alcázar Navarrete, Pedro J. Romero Palacios, Francisca Castellano Miñán, Oliverio Ruiz Rodriguez, Andres Ruiz Sancho. Temporal stability of feno measurement in COPD. Eur Respir J 2015; 46: Suppl. 59, 3994

Member's Comments

No comment yet.

Related content which might interest you: Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled nitric oxide in diagnosis and management of respiratory diseases Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled NO (FENO50) in COPD - Results from the TIE-study Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD) Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD Source: Eur Respir J 2010; 35: 72-78 Year: 2010 Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)? Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017 Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004 Using fractional exhaled nitric oxide level to differentiate asthma–COPD overlap syndrome from COPD Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Different patterns of exhaled NO response to acute bronchodilation in asthma Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 The acute and chronic effects of dietry nitrate on exercise tolerance in COPD patients Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Two sites of airway obstruction identified by post-bronchodilation change of exhaled nitric oxide in COPD patients Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Diagnostic value of FeNO in COPD and asthma - COPD overlap syndrome Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Further evidence that FeNO directed therapy reduces asthma exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 Cytokine status and nitrosative stress indicators in patients with an exacerbation of COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015